Fecal Microbiota Spores, Live

CHEMBL6068500 Phase 4 معتمد Unknown

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

— g/mol

LogP

—

Phase

4

This oral microbiome therapy consists of spores from a broad range of healthy gut bacteria derived from screened donor stool, used to restore a balanced gut microbiome. It is approved to reduce the recurrence of Clostridioides difficile infection.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

الأسئلة الشائعة

This oral microbiome therapy consists of spores from a broad range of healthy gut bacteria derived from screened donor stool, used to restore a balanced gut microbiome. It is approved to reduce the recurrence of Clostridioides difficile infection.

Yes, Fecal Microbiota Spores, Live is an approved drug. It has reached clinical phase 4. It is classified as a Unknown.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL6068500. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

PillFYI

هل تبحث عن معلومات ملائمة للمرضى؟

Fecal Microbiota Spores, Live على PillFYI

بيانات سريعة

روابط خارجية

ChEMBL CHEMBL6068500

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

إخلاء المسؤولية الطبية

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.